DE60008430D1 - Verbindungen mit antithrombotischer wirkung - Google Patents
Verbindungen mit antithrombotischer wirkungInfo
- Publication number
- DE60008430D1 DE60008430D1 DE60008430T DE60008430T DE60008430D1 DE 60008430 D1 DE60008430 D1 DE 60008430D1 DE 60008430 T DE60008430 T DE 60008430T DE 60008430 T DE60008430 T DE 60008430T DE 60008430 D1 DE60008430 D1 DE 60008430D1
- Authority
- DE
- Germany
- Prior art keywords
- antithrombotic effect
- formula
- compounds
- effect compounds
- novel compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16657599P | 1999-11-19 | 1999-11-19 | |
US166575P | 1999-11-19 | ||
PCT/US2000/028876 WO2001036414A1 (en) | 1999-11-19 | 2000-11-03 | Antithrombotic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60008430D1 true DE60008430D1 (de) | 2004-03-25 |
DE60008430T2 DE60008430T2 (de) | 2004-12-23 |
Family
ID=22603889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60008430T Expired - Fee Related DE60008430T2 (de) | 1999-11-19 | 2000-11-03 | Verbindungen mit antithrombotischer wirkung |
Country Status (7)
Country | Link |
---|---|
US (1) | US6620837B1 (de) |
EP (1) | EP1244655B1 (de) |
AT (1) | ATE259802T1 (de) |
AU (1) | AU1434201A (de) |
DE (1) | DE60008430T2 (de) |
ES (1) | ES2214332T3 (de) |
WO (1) | WO2001036414A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7275856B2 (en) | 2004-09-30 | 2007-10-02 | Rohm And Haas Electronic Materials Cmp Holdings, Inc. | Apparatus for forming a polishing pad having a reduced striations |
GB201311888D0 (en) * | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002500618A (ja) * | 1995-10-31 | 2002-01-08 | イーライ・リリー・アンド・カンパニー | 抗血栓性ジアミン |
DE69828522T2 (de) * | 1997-04-30 | 2005-12-15 | Eli Lilly And Co., Indianapolis | Antithrombotische mittel |
US6350774B1 (en) * | 1997-04-30 | 2002-02-26 | Eli Lilly And Company | Antithrombotic agents |
-
2000
- 2000-11-03 US US10/111,508 patent/US6620837B1/en not_active Expired - Fee Related
- 2000-11-03 DE DE60008430T patent/DE60008430T2/de not_active Expired - Fee Related
- 2000-11-03 AT AT00976590T patent/ATE259802T1/de not_active IP Right Cessation
- 2000-11-03 EP EP00976590A patent/EP1244655B1/de not_active Expired - Lifetime
- 2000-11-03 ES ES00976590T patent/ES2214332T3/es not_active Expired - Lifetime
- 2000-11-03 AU AU14342/01A patent/AU1434201A/en not_active Abandoned
- 2000-11-03 WO PCT/US2000/028876 patent/WO2001036414A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2001036414A1 (en) | 2001-05-25 |
ES2214332T3 (es) | 2004-09-16 |
EP1244655B1 (de) | 2004-02-18 |
US6620837B1 (en) | 2003-09-16 |
DE60008430T2 (de) | 2004-12-23 |
EP1244655A1 (de) | 2002-10-02 |
ATE259802T1 (de) | 2004-03-15 |
AU1434201A (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03005464A (es) | Agentes antivirales. | |
ATE306261T1 (de) | Antithrombosemittel | |
DE69830504D1 (de) | Antithrombotische mitteln | |
EE05103B1 (et) | Famatseutilised kompositsioonid, mis sisaldavad asetidiini derivaate, asetidiini derivaadid ja nende valmistamise meetodid | |
MXPA05002871A (es) | Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen. | |
EP1248612A4 (de) | Neue substanzen und verbindungen als protease-inhibitoren | |
SE9504661D0 (sv) | New compounds | |
CO5590918A2 (es) | Formulaciones | |
SE9900961D0 (sv) | Novel compounds | |
AP1564A (en) | Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use. | |
SE0100569D0 (sv) | New compounds | |
SE9802208D0 (sv) | Novel compounds | |
SE0102440D0 (sv) | New compound | |
DE69819539D1 (de) | Antithrombotische mittel | |
ATE308540T1 (de) | Antithrombosemittel | |
DE60131416D1 (de) | Chirale fluorochinolizinon arginine salze | |
SE9802209D0 (sv) | Novel compounds | |
DE69828522D1 (de) | Antithrombotische mittel | |
DE60005517D1 (de) | Kaliumkanal-blockierende mittel | |
SE0102057D0 (sv) | New Salts I | |
SE9504662D0 (sv) | New compounds | |
ATE284882T1 (de) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
DE60008430D1 (de) | Verbindungen mit antithrombotischer wirkung | |
SE0102058D0 (sv) | New Salts II | |
ATE268768T1 (de) | Antithrombosemittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |